Disclaimer: You are now leaving www.HIVReagentProgram.org and are going to a website that is not operated by NIH HIV Reagent Program. We are not responsible for the content or availability of linked sites.
ABOUT THIRD PARTY LINKS ON OUR SITE:
NIH HIV Reagent Program offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet. When you click on these links, you will leave the NIH HIV Reagent Program website and will be redirected to another site. These sites are not under the control of NIH HIV Reagent Program.
NIH HIV Reagent Program is not responsible for the content of linked third party websites. We are neither an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accuracy of the information contained in the linked sites. We suggest that you always verify the information obtained from linked websites before acting upon this information.
Please read third party privacy and security policies closely as these may be different than NIH HIV Reagent Program policies.
If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third party directly.
protected from moisture
ARP-4694 is a lentiviral
transducing vector containing the EF1a promoter-driven nuclear localized lacZ
gene. It is a self-inactivated lentiviral vector (pTY) that expresses the nlacZ
reporter gene. For
additional details please refer to the protocol for DNA transfection for
production of recombinant lentiviruses and the provided plasmid map and
Each vial of ARP-4694 contains
approximately 2 µg of dried purified DNA stabilized in DNAstable®PLUS. Please refer to the appropriate
data sheet for lot-specific information.
Chang, L.-J., et al. “Efficacy and Safety Analyses of a
Recombinant Human Immunodeficiency Virus Type 1 Derived Vector System.” Gene Ther. 6 (1999): 715-728.
Iwakuma, T., Y. Cui Y and L.-J. Chang. “Self-Inactivating
Lentiviral Vectors with U3 and U5 Mutations.” Virology 261
(1999): 120-132. PubMed:15750613.
Cui, Y., T. Iwakuma and L.-J.
Chang. “Contributions of Viral Splice Sites and Cis-Regulatory Elements to
Lentivirus Vector Function.” J.
Virol 73 (1999): 6171-6176.PubMed: 10364378.
Scientists at for-profit institutions or who intend
commercial use of this reagent must contact UF Innovate at the following email
before the reagent can be released.
When applying for permits and forms please:
Do NOT reference NIH HIV Reagent Program or ATCC Catalog Numbers in the Material Description
fields found on the permits and/or forms.
Make sure your name and address on the permit applications and/or forms are exactly
as they appear on your NIH HIV Reagent Program registration.
Information about permits is provided as a courtesy to NIH HIV Reagent Program customers.
While we use reasonable efforts to include accurate and up-to-date information on
this page, we make no warranties or representation as to its accuracy.
For more information on the necessary compliance requirements associated with the
biological materials provided by NIH HIV Reagent Program, please select this link: Compliance Requirements.
Knowledge Base (FAQs)
Microsoft PowerPoint Viewer
Microsoft Word Viewer
Microsoft Excel Viewer
Call Us Toll-Free:+1 (888) 487-0727
TTY:(703) 365 - 2727 (for deaf, hard of hearing, or speech impaired)